Update on progress of broad spectrum antibiotic RECCE 327 towards clinical trials
Pharmaceutical expert joins board of directors
Recce discusses synthetic antibiotic with FDA
Recce granted Qualified Infectious Disease Product Designation
Recce constructs automated manufacturing facility to support clinical trials
